Venmax Drugs and Pharmaceuticals informs about revised outcome of board meeting

Venmax Drugs And Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 531015 | NSE:

18 Feb 2023 Evaluate

Venmax Drugs and Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on Monday, the 30th January, 2023 at 4.00 PM at registered office of the Company, approved the un-audited Financial Results for the Quarter (Q3) and Nine Months ended December 31, 2022. The meeting commenced at 4.00 pm and concluded at 4.30 pm.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1853.00
Dr. Reddys Labs.	1200.40
Cipla	1404.00
Lupin	2098.00
Zydus Lifesciences	1180.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.